ATOS

NASD Atossa Therapeutics, Inc.
Oct 17, 2026 · 3:04 PM ET EOD Market Closed

$2.91 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.91, $0.04 below the day’s high of $2.95

YTD change
-67.12%
vs 20-day SMA
+26.61%
vs 200-day SMA
-32.84%

Price ranges

Previous day
$2.51 $2.95
open $2.59 close $2.91
+$0.32 (+12.36%)
Today
$2.51 $2.95
$2.91
Past week
$2.12 $3.12
from $2.42 now $2.91
+$0.49 (+20.25%)
Past month
$1.82 $3.12
from $2.40 now $2.91
+$0.51 (+21.25%)
This year
$0.53 $8.85
from $8.85 now $2.91
-$5.94 (-67.12%)

Price & Performance

-2.92 (-50.09%) / 6M

$1.40$3.11$4.81$6.52Apr 17Jul 20Oct 16

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 99.4% away from all-time highs of $468.00
  • ATOS is down 67% since the beginning of the year
  • ATOS is down 81% over the past 12 months
  • ATOS is up 21% over the past 1 month
  • 8% of all ATOS investors are betting against ATOS

ATOS reads neutral: price sits above one of the two key moving averages, the 12-month move is +197.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.95
Earnings momentum -10.9% Quarterly EPS growth
Quarterly change -10.9%

Valuation

P/E ratio N/A
Enterprise value $-2596440.0
Beta 1.76

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$26.2M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $29.0M

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $432.49 -0.35%
MRNA Moderna, Inc. $218.01 -7.82%
RVMD Revolution Medicines, Inc. $177.96 -5.97%
ROIV Roivant Sciences Ltd. $33.53 -1.50%
BNTX BioNTech SE Sponsored ADR $87.71 -2.76%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.